These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39039949)

  • 1. In vitro metabolism study of ADB-P-5Br-INACA and ADB-4en-P-5Br-INACA using human hepatocytes, liver microsomes, and in-house synthesized references.
    Rautio T; Obrist R; Krebs L; Klingstedt T; Dahlén J; Wu X; Gréen H
    Drug Test Anal; 2024 Jul; ():. PubMed ID: 39039949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC-QTOF-MS and synthesized reference standards.
    Baginski SR; Rautio T; Nisbet LA; Lindbom K; Wu X; Dahlén J; McKenzie C; Gréen H
    J Anal Toxicol; 2023 Dec; 47(9):826-834. PubMed ID: 37747838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons.
    Kronstrand R; Norman C; Vikingsson S; Biemans A; Valencia Crespo B; Edwards D; Fletcher D; Gilbert N; Persson M; Reid R; Semenova O; Al Teneiji F; Wu X; Dahlén J; NicDaéid N; Tarbah F; Sutcliffe OB; McKenzie C; Gréen H
    Drug Test Anal; 2022 Apr; 14(4):634-652. PubMed ID: 34811926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogs.
    Deventer MH; Persson M; Norman C; Liu H; Connolly MJ; Daéid NN; McKenzie C; Gréen H; Stove CP
    Drug Test Anal; 2024 Jun; 16(6):616-628. PubMed ID: 37903509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UPLC-HR-MS/MS-based determination study on the metabolism of four synthetic cannabinoids, ADB-FUBICA, AB-FUBICA, AB-BICA and ADB-BICA, by human liver microsomes.
    Li J; Liu C; Li T; Hua Z
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 28992356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.
    Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R
    AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Carlier J; Diao X; Wohlfarth A; Scheidweiler K; Huestis MA
    Curr Neuropharmacol; 2017 Jul; 15(5):682-691. PubMed ID: 29403341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the Metabolic Profiles of "Indazole-3-Carboxamide" and "Isatin Acyl Hydrazone" (OXIZID) Synthetic Cannabinoids in a Human Liver Microsome Model Using UHPLC-QE Orbitrap MS.
    Xiang J; Wen D; Zhao J; Xiang P; Shi Y; Ma C
    Metabolites; 2023 Apr; 13(4):. PubMed ID: 37110234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of ADB-BUTINACA Metabolites in Human Urine, Blood, Kidney and Liver.
    Kavanagh P; Pechnikov A; Nikolaev I; Dowling G; Kolosova M; Grigoryev A
    J Anal Toxicol; 2022 Jul; 46(6):641-650. PubMed ID: 34341821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5-bromo-indazole-3-carboxamide synthetic cannabinoid receptor agonists.
    Norman C; Webling K; Kyslychenko O; Reid R; Krotulski AJ; Farrell R; Deventer MH; Liu H; Connolly MJ; Guillou C; Vinckier IMJ; Logan BK; NicDaéid N; McKenzie C; Stove CP; Gréen H
    Drug Test Anal; 2024 Sep; 16(9):915-935. PubMed ID: 38037247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Phase I Metabolism of the Recently Emerged Synthetic MDMB-4en-PINACA and Its Detection in Human Urine Samples.
    Erol Ozturk Y; Yeter O
    J Anal Toxicol; 2021 Jan; 44(9):976-984. PubMed ID: 32091101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.
    Takayama T; Suzuki M; Todoroki K; Inoue K; Min JZ; Kikura-Hanajiri R; Goda Y; Toyo'oka T
    Biomed Chromatogr; 2014 Jun; 28(6):831-8. PubMed ID: 24861751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.
    Carlier J; Diao X; Wohlfarth A; Scheidweiler K; Huestis MA
    Curr Neuropharmacol; 2016 Nov; ():. PubMed ID: 27829332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simultaneous determination of five indole/indazole amide-based synthetic cannabinoids in electronic cigarette oil by ultra performance liquid chromatography].
    Yang Z; Lyu JX; Wu YD; Jiang LW; Li DM
    Se Pu; 2023 Jul; 41(7):602-609. PubMed ID: 37387281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic profiles and screening tactics for MDMB-4en-PINACA in human urine and serum samples.
    Gu K; Qin S; Zhang Y; Zhang W; Xin G; Shi B; Wang J; Wang Y; Lu J
    J Pharm Biomed Anal; 2022 Oct; 220():114985. PubMed ID: 35985137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse.
    Sia CH; Wang Z; Goh EML; Tan YL; Fong CY; Moy HY; Chan ECY
    Clin Chem; 2021 Nov; 67(11):1534-1544. PubMed ID: 34387654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances.
    Qian Z; Hua Z; Liu C; Jia W
    Forensic Toxicol; 2016; 34():133-143. PubMed ID: 26793280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cannabinoid-like effects and pharmacokinetics of ADB-BICA, ADB-BINACA, ADB-4en-PINACA and MDMB-4en-PINACA in mice: A comparative study.
    Zhou F; Wang X; Tan S; Shi Y; Xie B; Xiang P; Cong B; Ma C; Wen D
    Addict Biol; 2024 Feb; 29(2):e13372. PubMed ID: 38380735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.
    Kusano M; Zaitsu K; Taki K; Hisatsune K; Nakajima J; Moriyasu T; Asano T; Hayashi Y; Tsuchihashi H; Ishii A
    Drug Test Anal; 2018 Feb; 10(2):284-293. PubMed ID: 28544560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.